Ikena Oncology Stock Forecast - 4 Period Moving Average
| IKNA Stock | USD 1.26 0.02 1.61% |
The 4 Period Moving Average forecasted value of Ikena Oncology on the next trading day is expected to be 1.26 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.90. Ikena Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ikena Oncology stock prices and determine the direction of Ikena Oncology's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ikena Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Ikena Oncology's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Ikena Oncology's systematic risk associated with finding meaningful patterns of Ikena Oncology fundamentals over time.
Check out Historical Fundamental Analysis of Ikena Oncology to cross-verify your projections. Ikena |
Most investors in Ikena Oncology cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Ikena Oncology's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Ikena Oncology's price structures and extracts relationships that further increase the generated results' accuracy.
A four-period moving average forecast model for Ikena Oncology is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility. Ikena Oncology 4 Period Moving Average Price Forecast For the 20th of April
Given 90 days horizon, the 4 Period Moving Average forecasted value of Ikena Oncology on the next trading day is expected to be 1.26 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 2.90.Please note that although there have been many attempts to predict Ikena Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ikena Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Ikena Oncology Stock Forecast Pattern
| Backtest Ikena Oncology | Ikena Oncology Price Prediction | Buy or Sell Advice |
Ikena Oncology Forecasted Value
In the context of forecasting Ikena Oncology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ikena Oncology's downside and upside margins for the forecasting period are 0.01 and 5.78, respectively. We have considered Ikena Oncology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Ikena Oncology stock data series using in forecasting. Note that when a statistical model is used to represent Ikena Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 105.3572 |
| Bias | Arithmetic mean of the errors | 0.0036 |
| MAD | Mean absolute deviation | 0.0508 |
| MAPE | Mean absolute percentage error | 0.0359 |
| SAE | Sum of the absolute errors | 2.8975 |
Predictive Modules for Ikena Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ikena Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ikena Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Ikena Oncology
For every potential investor in Ikena, whether a beginner or expert, Ikena Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ikena Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ikena. Basic forecasting techniques help filter out the noise by identifying Ikena Oncology's price trends.View Ikena Oncology Related Equities
| Risk & Return | Correlation |
Ikena Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ikena Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ikena Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ikena Oncology Market Strength Events
Market strength indicators help investors to evaluate how Ikena Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ikena Oncology shares will generate the highest return on investment. By undertsting and applying Ikena Oncology stock market strength indicators, traders can identify Ikena Oncology entry and exit signals to maximize returns.
Ikena Oncology Risk Indicators
The analysis of Ikena Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ikena Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ikena stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.18 | |||
| Standard Deviation | 4.58 | |||
| Variance | 20.95 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Ikena Oncology to cross-verify your projections. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Ikena Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ikena Oncology. If investors know Ikena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ikena Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.63) | Revenue Per Share 0.219 | Quarterly Revenue Growth (0.88) | Return On Assets (0.26) | Return On Equity (0.43) |
The market value of Ikena Oncology is measured differently than its book value, which is the value of Ikena that is recorded on the company's balance sheet. Investors also form their own opinion of Ikena Oncology's value that differs from its market value or its book value, called intrinsic value, which is Ikena Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ikena Oncology's market value can be influenced by many factors that don't directly affect Ikena Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ikena Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ikena Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ikena Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.